子類別 會議論文/會議摘要 [7/13] 期刊論文 [42/42] 鄰近社群 伍素瑩 [52/65] 其他 [58/60] 夏克山 [76/98] 岳嶽 [29/32] 張仲明 [7/9] 張俊彥 [18/18] 張竣評 [21/26] 徐祖安 [170/215] 李秀珠 [75/105] 李靜琪 [23/24] 林書玉 [19/20] 洪明秀 [31/40] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [35/39] 童俊維 [23/23] 紀雅惠 [21/25] 翁紹華 [22/24] 莊宏 [1/1] 葉修華 [24/25] 葉燈光 [133/152] 蔣維棠 [41/66] 謝興邦 [171/231] 趙宇生(2002-2013) [120/212] 鄒倫 [28/29] 陳志豪 [31/52] 陳新(2002-2015) [53/67] 陳炯東 [180/212] 顏婉菁 [6/7] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] 社群統計 近3年內發表的文件:6(10.91%) 含全文筆數:49(89.09%) 文件下載次數統計 下載大於0次:49(100.00%) 下載大於100次:49(100.00%) 檔案下載總次數:22788(0.43%) 最後更新時間: 2024-11-28 12:20 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Lysosomal-targeted doxorubicin deli... How to deal with frenemy NRF2: Targ... Synthesis and structure–activity re... Pilot study: Nutritional and precli... A novel NRF2/ARE inhibitor gossypol... Discovery and development of a nove... Type-3 hyaluronan synthase attenuat... Two new chromones and a new coumari... Xanthine derivatives reveal an allo... c-MYC-directed NRF2 drives malignan...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 55. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2023-11	Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death	Pharmacological Research. 2023 Nov;197:Article number 106945.
2023-03-28	Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors	International Journal of Molecular Sciences. 2023 Mar 28;24(7):Article number 6386.
2023-02-28	How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy	Journal of Food and Drug Analysis. 2023 Feb 28;31(3):387-407.
2023-01	Two new chromones and a new coumarin from the fruit of Cnidium monnieri (L.) Cusson	Natural Product Research. 2023 Jan;37(1):47-55.
2022-02-05	Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design	European Journal of Medicinal Chemistry. 2022 Feb 5;229:Article number 114043.
2022-01-17	Pilot study: Nutritional and preclinical safety investigation of fermented hispidin-enriched sanghuangporus sanghuang mycelia: A promising functional food material to improve sleep	Frontiers in Nutrition. 2022 Jan 17;8:Article number 788965.
2021-12-14	A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells	Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-10-29	Type-3 hyaluronan synthase attenuates tumor cells invasion in human mammary parenchymal tissues	Molecules. 2021 Oct 29;26(21):Article number 6548.
2021-08-12	Xanthine derivatives reveal an allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2)	Journal of Medicinal Chemistry. 2021 Aug 12;64(15):11288-11301.
2021-03-15	Tea polyphenol epigallocatechin-3-gallate inhibits cell proliferation in a patient-derived triple-negative breast cancer xenograft mouse model via inhibition of proline-dehydrogenase-induced effects	Journal of Food and Drug Analysis. 2021 Mar 15;29(1):113-127.
2021-03-11	c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation	Theranostics. 2021 Mar 11;11(11):5232-5247.
2020-08	Two new diprenylated flavanones from Derris laxiflora Benth	Natural Product Research. 2020 Aug;34(15):2101-2108.
2020-04-02	MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer	Journal of Biomedical Science. 2020 Apr 2;27:Article number 46.
2020-02-10	Unique sulfur-aromatic interactions contribute to the binding of potent imidazothiazole indoleamine 2,3-Dioxygenase inhibitors	Journal of Medicinal Chemistry. 2020 Feb 10;63(4):1642-1659.
2019-12-24	ERK activation modulates cancer stemness and motility of a novel mouse oral squamous cell carcinoma cell line	Cancers. 2019 Dec 24;12(1):Article number 61.
2019-12	Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia	Journal of Medicinal Chemistry. 2019 Dec;62(24):11135-11150.
2019-08	Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy	Cancer Medicine. 2019 Aug;8(10):4821-4835.
2019-07	Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216	Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 4626.
2019-05	A novel mechanism of miRNA-mediated CBX8 associated with tumorigenesis in head and neck squamous cell carcinoma	Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number e17534.
2018-12	Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells	Biochemical Pharmacology. 2018 Dec;158:327-338.
2018-12	Establishment and characterization of novel syngeneic oral squamous cell carcinoma mouse cell lines	Cancer Science. 2018 Dec;109(Suppl. 2):386.
2018-07	4-Bromophenylhydrazinyl benzenesulfonylphenylureas inhibit indoleamine 2,3-dioxygenase in vitro and in vivo	Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 1664.
2018-07	Clinical candidate DBPR112: A novel epidermal growth factor receptor inhibitor as a promising treatment for non-small cell lung cancer	Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 4789.
2018-07	Blockage of EGFR signaling repurposes tumor metabolism through suppression of glycolysis and Kreb cycle in head and neck cancer	Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 3944.
2018-06-15	2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition [Erratum: Organic and Biomolecular Chemistry. 2016 Jan;14(2):716-723.]	Organic and biomolecular chemistry. 2018 Jun 15;16:4734.

顯示項目1-25 / 55. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目